Cite
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
MLA
Laidlaw, Tanya M., et al. Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1405292156&authtype=sso&custid=ns315887.
APA
Laidlaw, T. M., Menzies-Gow,Andrew, Caveney,Scott, Han, J. K., Martin,Nicole, Israel,Elliot, Lee, J. K., Llanos,Jean-Pierre, Martin,Neil, Megally,Ayman, Parikh,Bhavini, Vong,Sylvia, Welte,Tobias, & Corren,Jonathan. (2023). Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum].
Chicago
Laidlaw, Tanya M, Menzies-Gow,Andrew, Caveney,Scott, Joseph K Han, Martin,Nicole, Israel,Elliot, Jason K Lee, et al. 2023. “Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum].” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1405292156&authtype=sso&custid=ns315887.